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Abstract Previous studies report associations between
conception with assisted reproductive technology (ART)
and autism. Whether these associations reflect an ascer-
tainment or biologic effect is undetermined. We assessed
diagnosis age and initial autism symptom severity among
[30,000 children with autism from a linkage study of
California Department of Developmental Services records,
birth records, and the National ART Surveillance System.
Median diagnosis age and symptom severity levels were
significantly lower for ART-conceived than non-ART-
conceived children. After adjustment for differences in the
socio-demographic profiles of the two groups, the diagno-
sis age differentials were greatly attenuated and there were
no differences in autism symptomatology. Thus, ascer-
tainment issues related to SES, not ART per se, are likely
the driving influence of the differences we initially
observed.
Keywords Infantile autism  Symptom severity 
Diagnosis age  Assisted reproductive technology
Introduction
Both assisted reproductive technology (ART) and autism
spectrum disorder (ASD) have increased dramatically in
past decades (Autism and Developmental Monitoring
Network Surveillance Year 2008 Principal Investigators
2012; Blumberg et al. 2013; Baron-Cohen et al. 2009;
Roelfsema et al. 2012; Schieve et al. 2012b; CDC et al.
2012). Current estimates of ASD prevalence among US
children are between 1 and 2 %, with studies indicating a
greater than 70 % increase in just the past decade (Autism
and Developmental Monitoring Network Surveillance Year
2008 Principal Investigators 2012; Autism and Develop-
mental Monitoring Network Surveillance Year 2010 Prin-
cipal Investigators 2014; Blumberg et al. 2013). The annual
number of ART births in the US has tripled between 1996
and 2011; the most recent annual estimate is over 60,000
births, approximately 1.5 % of the 2011 US birth cohort
(Sunderam et al. 2014). ART is defined in the US and many
other national registries as inclusive of only the most in-
tensive infertility treatments, such as in vitro fertilization,
in which both sperm and eggs are handled outside of the
body.
Several large population-based studies from various
countries document that overall, the prevalence of autism
or ASD diagnoses is moderately higher among children
conceived with ART than among children in the general
population (Hvidtjorn et al. 2009, 2011; Sandin et al. 2013;
Fountain et al. 2015); however, associations were generally
reduced after control of socio-demographic and perinatal
factors, such as multiple birth. We recently assessed this
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association in a large US population-based cohort (Foun-
tain et al. 2015) and observed that the ART-autism asso-
ciation was attenuated after (1) adjustment for socio-
demographic factors, such as maternal education and race,
likely related to parents’ awareness of ASD and access to
and ability to navigate the healthcare system and (2) ad-
justment for several potential mediating factors—multiple
birth, preterm birth (PTB), fetal growth restriction and
maternal complications. Our previous study along with
other population-based assessments suggests that while
ART is associated with ASD, it likely only has a modest, if
any, direct effect on ASD etiology.
In the current study, we further explore whether and to
what extent the ART-autism association is specifically
driven by differences in autism identification patterns be-
tween ART- and non-ART-conceived children. We asses-
sed child’s age and symptom severity at autism
identification. Trends toward both earlier identification and
increased identification of children with less ‘‘severe’’
symptom profiles across all ages have been shown to be
notable contributors to the increased US prevalence of
identified ASD overall (Shattuck et al. 2009; Autism and
Developmental Monitoring Network Surveillance Year
2006 Principal Investigators 2009; Autism and Develop-
mental Monitoring Network Surveillance Year 2008 Prin-
cipal Investigators 2012; Schieve et al. 2012b; Blumberg
et al. 2013). We assessed whether these dynamics were
especially pronounced among children conceived with
ART. For several reasons, parents and healthcare providers
might monitor ART-conceived children more closely than
other children for health and developmental difficulties.
ART-conceived children are typically from families with
higher than average socioeconomic status and thus better
than average access to healthcare (Schieve et al. 2007);
their parents have experience navigating the complex
health care system for infertility treatment, and this could
certainly translate to being more savvy in navigating the
pediatric care system; ART-conceived children are more
likely than non-ART-conceived children to have an ad-
verse perinatal outcome, such as PTB or low birth weight
(Farhi et al. 2013; Schieve et al. 2007); and ART mothers
might be more likely to be concerned about their baby’s
health generally (Barnes et al. 2012).
We assessed diagnosis age and levels of initial social
and communication deficits for California children born
between 1997 and 2006 who were subsequently diagnosed
with autism. We compared children conceived with ART to
those not conceived with ART. Additionally, we assessed
various subgroups of the population and controlled for
socio-demographic factors and adverse perinatal outcomes
to better understand the reasons for any differences ob-
served between ART- and non-ART-conceived children.
Methods
Data Sources
We used data from a previous linkage of three large
population-based datasets: the California Birth Master
Files (BMF) for 1997–2007, the California Department of
Developmental Services (DDS) autism caseload records for
1997–2011 (an administrative database known as CDER,
client development evaluation reports), and the Centers for
Disease Control and Prevention’s (CDC’s) National ART
Surveillance System (NASS).
The California DDS is a statewide agency responsible
for coordinating diagnoses and services for persons with
developmental disabilities including autism. Children are
referred to DDS regional centers from health-care provi-
ders, educators, service agencies, public health clinics, and
parents. To quality for services, a child must have a certain
level of functional deficit. While children with Autistic
Disorder (DSM-IV code 299.0) have generally qualified,
those with other ASDs, generally have not. Thus, these data
represent a subset of children with ASD—those likely to
have more significant functional limitations. We thus use
the terminology autism throughout this report to describe
our study population, rather than the broader term, ASD.
Although autism cases included in the DDS are not iden-
tified through systematic population surveillance, eligi-
bility for services is based on diagnostic and not financial
criteria, and thus, the system captures the vast majority of
the population. Even so, it is possible that certain popula-
tion subgroups are over-represented, such as children from
families with socioeconomic advantages who are able to
navigate the complex system more easily. CDER is one of
the largest administrative sources of data on autism diag-
noses in the US Moreover, a previous comparison of a
random sample of CDER autism cases with medical record
data indicates high reliability (Croen et al. 2002a).
NASS includes data on women who receive ART ser-
vices from healthcare providers in the United States and its
territories. US clinics and medical practices are federally
mandated to annually report data to the CDC for every ART
procedure initiated (United States 1992). While 5–10 % of
clinics do not report as mandated, many non-reporting
clinics are thought to be smaller than average practices be-
cause they are either new practices or practices in process of
reorganizing or closing (CDC et al. 2012). Data in NASS are
abstracted by clinic personnel from patient records; in ad-
dition to clinical information on each ART treatment, data
are abstracted on resultant pregnancies and pregnancy out-
comes. Pregnancy outcome data are obtained for 99 % of all
ART pregnancies, often through active follow-up. Annual
on-site data validation visits at a sample of reporting clinics
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have consistently confirmed the accuracy of pregnancy and
birth reporting (CDC et al. 2012).
Linkage Procedures
The linkage procedure has been previously described
(Zhang et al. 2012). Briefly, we selected from NASS the
subset of ART procedures that were performed on in-state
residents in California clinics/medical practices and re-
sulted in a live birth. These data were linked to the BMF
based on mother’s date of birth, infant’s date of birth,
plurality, mother’s ZIP code, and gravidity. Uncertain
matches were manually reviewed, and infant sex, maternal
race, and infant birth weight were used to resolve duplicate
or uncertain matches. Ninety percent of the ART births
selected from NASS for this study were successfully linked
to a California birth from BMF.
Autism cases from CDER were also linked to BMF
probabilistically on first and last names, middle initial, date
of birth, sex, race/ethnicity, and maternal zip code. Uncer-
tain matches were manually reviewed. On average, 86 % of
eligible children with autism in CDER were linked to a birth
record. This linkage rate is in line with data from a previous
linkage study of the same two datasets (Croen et al. 2002a).
Typically, CDER data that could not bematched belonged to
children born outside of California who had moved into the
state at some time after their births.
This protocol was approved by the Institutional Review
Boards at Columbia University and the Centers for Disease
Control and Prevention, and by the California Committee
for the Protection of Human Subjects.
Study Population
Our sample selection is illustrated in Fig. 1. Between 1997
and 2006, there were 5,359,961 children born to California
resident mothers. In our initial analyses, we selected from
this population, 30,483 children who were subsequently
diagnosed with autism through the DDS system; 530 of
these children were conceived with ART.
We conducted a series of analyses using 3 samples. Our
initial sample consisted of the total population of 30,483
children with autism. Our second sample was constructed
from this initial sample. We restricted the sample to ac-
count for the marked differential in the socio-demographic
profile for ART versus non-ART births. We thus excluded
children whose mothers were less than 20 years of age at
the time of their birth, had less than a high school diploma,
had prenatal care or delivery paid for by Medi-Cal or other
public source, or had missing information on prenatal care,
inadequate prenatal care (Kotelchuck 1994) or started
prenatal care in the third trimester. Additionally, we ex-
cluded infants with missing values for other socio-demo-
graphic factors that were included as covariates in our
statistical models (about 4 %, of the sample). Within each
of the aforementioned population subgroups excluded from
our second sample, the proportion of ART births was
B3.0 %; thus, sample restriction was preferable to solely
using statistical adjustment to account for potential con-
founding factors (i.e. the likelihood of residual confound-
ing was high for statistical adjustment alone). This sample
restricted for socio-demographic comparability (henceforth
referred to as the restricted sample) included 17,075 infants
of whom 492 were conceived with ART. It is notable that
while nearly half of the non-ART births in our initial
sample were excluded from our restricted sample, only 7 %
of ART births were excluded. This highlights our rationale
for sample restriction. In our final analytic sample, we
additionally excluded children who were born in a multi-
ple-birth delivery and children missing gestational age and
birthweight data. Multiple births were excluded from this
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Fig. 1 Sample selection process and sample sizes according to whether a child was conceived with ART
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perinatal mediators; multiple births are strongly associated
with the use of ART and convey a much higher risk for
adverse maternal and infant health outcomes and child
disability than singleton births (Schieve 2007). This sam-
ple, henceforth referred to as the restricted singleton sam-
ple, included 15,999 children of whom 185 were conceived
with ART.
For certain analyses—those assessing communication
level, and social functioning at initial DDS assessment—
each of our analytic samples was further reduced. Because
of changes in the rating items that comprised these two
measures (see below), we were only able to include chil-
dren born between 1997 and 2004 in those analyses.
Outcomes
Our outcomes of interest -age at autism diagnosis, autism
communication and social functioning severity indicators,
and co-occurring ID—were derived from CDER data. Di-
agnosis age was calculated from date of birth and date of
first DDS evaluation. California requires that all children
receiving DDS services are confirmed as meeting eligi-
bility for services through verification or confirmation of a
diagnosis within 120 days of intake; thus, the first DDS
visit date is considered to be very close to diagnosis date.
Because children with developmental delays who are
younger than 3 years of age are served by the Early Start
Program, age at diagnosis in those younger than three is
rarely found in the DDS records. We assessed both mean
and median age at diagnosis as well as percentage of
children with early diagnosis, defined here as\4 years of
age.
At a child’s first DDS evaluation, communication and
social functioning are systematically assessed via ratings
for a series of Likert-scale items, and these ratings are
recorded in the CDER. Communication items include:
word usage; receptive language; and expressive language.
Social functioning items include: level of social interaction
with peers; level of social interaction with non-peers;
friendship formation and maintenance; and participation in
social activities. We created indices for communication
and social functioning by combining scores for all items for
a given domain; for each index, individual items within the
domain were weighted equally (Fountain et al. 2012). The
specific items used to assess both communication and so-
cial functioning changed in 2008 and thus, the children
included in our study population were assessed using two
different (albeit related) metrics. Children born between
1997 and 2004 were primarily assessed with the pre-2008
criteria, while children born in 2005–2006 were assessed
with the newer criteria. We attempted to harmonize the two
indices into a common set of criteria for analyses. We used
two approaches—one based on empirical assessments of
item frequencies and one based on a priori expert clinical
judgment. Neither process produced satisfactory results;
thus, we limit our assessment of the communication and
social functioning outcomes to children born between 1997
and 2004 who were assessed using the pre-2008 criteria
(N = 19,518 for the initial sample). For these children, we
first assessed the overall distributions of the calculated
communication and social index scores. We defined low
functioning for each index as having a score in the bottom
tertile.
In addition to the functional indices for core autism
symptomatology, we also assessed the percentage of chil-
dren with a co-occurring diagnosis of ID (IQ \70), an
indicator related to one aspect of condition severity. We
lacked access to IQ data to further refine this indicator to
assess various levels of intellectual functioning among
children with and without ID. Additionally, it is likely that
for a proportion of children with autism who had co-oc-
curring ID, the ID classification was not included in the
CDER database. An early reliability study based on med-
ical record review indicated that while autism was reliably
reported in CDER, there was a noteworthy level of under-
reporting of co-occurring ID among children with autism
(Croen et al. 2002b). Also, because CDER is an adminis-
trative rather than a research database, children are not
necessarily systematically assessed for all developmental
conditions. The focus is on service provision, and thus, a
child with autism might not be assessed for all secondary
conditions if services being provided for the primary con-
dition will also cover his/her secondary functional deficits.
Even though we believe ID was underreported, we have no
reason to believe the level of under-reporting varied by
mode of conception. Thus, we included it in our analyses as
an adjunct severity indicator.
ART
ART was defined to include nearly all types of ART re-
ported to NASS: treatments in which freshly-fertilized
embryos created using the intended mother’s own eggs
were transferred; treatments in which freshly-fertilized
embryos created using another woman’s (donor) eggs were
transferred; treatments in which previously frozen, thawed
embryos created using either the intended mother’s or
donor eggs were transferred; treatments using standard
in vitro fertilization techniques as well as treatments using
intracytoplasmic sperm injection (ICSI), and treatments
using the more standard trans-cervical embryo transfer
technique as well as those using gamete or zygote in-
trafallopian transfer (GIFT, ZIFT). However, ART in this
analysis does not include the very small percentage of
procedures in which embryos that were created using an
ART were transferred into a woman other than the intended
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mother (a gestational surrogate), because these types of
procedures were excluded from the NASS-birth certificate
linkage. Also, NASS defines ART as including only those
procedures in which egg and sperm are handled outside the
body; thus infertility treatments such as ovulation
stimulation only without egg retrieval and artificial in-
semination are not collected in NASS.
Covariates and Causal Path Factors
In all adjusted models we included child sex, maternal age
at child’s birth, maternal educational level at child’s birth,
maternal race-ethnicity and maternal immigration status
(US versus foreign-born) as potential confounders. In our
final models, we additionally included two factors poten-
tially in the causal pathway for the ART-ASD association,
PTB and small-for-gestational-age (SGA). Adverse peri-
natal outcomes have been found to be associated with ART
use previously, even when considering singleton deliveries
only (Schieve et al. 2007). All covariates were derived
from birth certificate data. PTB was defined as gestational
age\37 completed weeks (based on last menstrual period
or clinical estimate when missing). SGA was defined as
birthweight-for-gestational age\10th % of a US referent
population (Oken et al. 2003).
Statistical Analysis
We evaluated all diagnosis age outcomes and co-occurring
ID in four sets of analyses: (1) unadjusted analyses of our
total study population of children diagnosed with autism;
(2) analyses of the restriction sample with additional ad-
justment for demographic factors; (3) analyses of restrict-
ed, singleton sample with additional adjustment for
demographic factors; (4) analyses of restricted, singleton
sample with additional adjustment for both demographic
and causal path factors. We evaluated communication and
social functioning outcomes in the first two analyses sets
only; sample sizes were insufficient to include these out-
comes in the third and fourth sets.
For all dichotomous outcomes, we calculated odds ratios
(ORs) and 95 % confidence intervals in which the odds of
the outcome among ART-conceived children were com-
pared to the odds for non-ART-conceived children. Ad-
justed ORs were computed using logistic regression.
We also assessed the mean and median diagnosis age for
ART- versus non-ART-conceived children and calculated
the mean differences using linear regression models with
log-transformed age values to account for skewed data. We
included the same adjustment factors in these models as for
dichotomous outcomes in analyses sets 2 through 4. We
used SAS statistical software version 9.3 (SAS Institute) to
conduct all analyses.
All analyses were conducted within birth year strata
(1997–1999; 2000–2002; 2003–2004; 2005–2006) as well
as for the total sample. Because both ART and autism have
increased over time, it is feasible that diagnosis age and
autism severity level at initial assessment have changed as
well.
Results
In all three of our analytic samples, ART-conceived chil-
dren were more likely than non-ART conceived children to
be female and to be from more recent birth cohorts
(Table 1). In all three samples, mothers of ART-conceived
children were more likely than mothers of non-ART—
conceived children to be non-Hispanic white (NHW), and
they were less likely to be Hispanic and born outside the
US. Additionally at the time of the child’s birth, ART
mothers were substantially more likely than non-ART
mothers to be primiparous, older, to have completed four or
more years of college, and to have received greater than
adequate prenatal care. In the total and the restriction
samples, [60 % of ART-conceived children were from
multiple births versus \5 % among non-ART-conceived
children and thus, ART-conceived children were also much
more likely to be born PTB and SGA. However, even in the
restricted, singleton sample, ART-conceived children were
more likely than non-ART-conceived children to have PTB
and SGA.
Comparisons of ART- and non-ART-conceived children
on autism diagnosis age are presented in Tables 2 and 3.
We found that for the total study population of children
with autism, those conceived with ART had significantly
lower mean and median autism diagnosis ages than those
not conceived with ART (Table 2). This finding was con-
sistent for all birth cohorts except the most recent
(2005–2006). Children conceived via ART and born in
1997–1999 had mean and median diagnosis ages of 4.6 and
3.8 years, respectively. These compare to 5.3 and 4.4 years
for the non-ART births during the same time period. In
contrast, for the 2005–2006 birth cohorts, mean and me-
dian diagnosis ages were notably lower for both ART (3.6
and 3.4 years) and non-ART conceived children (3.7 and
3.5 years). For the total study population, mean diagnosis
age was 0.1 year (1.2 months) earlier for ART than non-
ART conceived children and this difference was statisti-
cally significant (Table 3).
While mean andmedian diagnoses ages were very similar
for those children retained in the restricted sample as those
for children in the total sample (Table 2), after additional
adjustment for socio-demographic factors the differential
between ART and non-ART children in the restricted sam-
ple was greatly reduced and not statistically significant for
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Table 1 Percentage distributions of socio-demographic and perinatal factors by ART status in the total study population of children with autism
and analytic subsamples
Total population of children with
autism
Sample restricted for socio-
demographic comparability















1997–1999 21.1 25.1 20.5 26.0 21.1 26.3
2000–2002 31.1 31.2 31.5 32.5 28.1 32.7
2003–2004 22.1 23.2 22.2 22.6 20.0 22.5
2005–2006 25.7 20.5 25.8 18.9 30.8 18.6
Child sex
Female 20.2 16.8 19.5 16.8 18.4 16.7
Male 79.8 83.2 80.5 83.2 81.6 83.3
Maternal race/ethnicity
Non-Hispanic white 66.8 34.0 68.1 45.8 69.2 45.6
Non-Hispanic black 4.2 7.5 3.9 6.6 4.9 6.0
Hispanic 12.3 41.1 11.4 24.9 7.0 24.9
Asian/Pacific Islander 14.9 15.9 14.8 21.2 17.8 21.4
Other/unknown 1.9 1.5 3.4 1.5 –a 1.5
Maternal birthplace
US and territories 71.3 56.1 72.2 63.6 71.4 63.2
Outside US 28.7 43.9 27.9 36.4 28.7 36.8
Maternal education at child’s birth
\high school 1.4 19.1 – – – –
High school 8.2 26.6 7.4 22.9 4.0 23.0
Some college 21.3 24.7 21.9 30.2 17.0 30.5
4-year college grad ? 69.1 29.6 70.8 46.9 79.1 46.5
Maternal age (y) at child’s birth
\20 0 5.2 – – – –
20–24 – 18.1 0.6 10.6 – 10.8
25–29 5.3 25.8 4.9 25.4 3.8 25.7
30–34 25.1 28.2 24.8 34.9 18.9 34.8
35–39 33.8 18.1 33.7 23.2 36.2 22.8
40? 35.3 4.7 36.0 5.9 40.0 5.8
Parity at child’s birth
Primiparous 55.1 43.2 55.7 46.7 82.7 47.8
Multiparous 44.9 56.8 44.3 53.3 17.3 52.2
Prenatal care initiation
First trimester 98.3 88.9 98.6 96.5 97.8 96.4
Second trimester 1.4 9.2 1.4 3.5 - 3.6
Third trimester – 1.6 – – – –
No prenatal care 0 0.3 – – – –
Adequacy of prenatal care
Inadequate – 6.9 – – – –
Intermediate 2.8 11.5 2.9 12.0 5.4 12.5
Adequate 14.9 40.9 16.1 45.2 30.8 46.7
Adequate ? 78.9 38.4 81.1 42.8 63.8 40.7
Missing 2.8 2.4 – – – –
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most birth cohorts (Table 3). Still, for all birth cohorts
combined, mean diagnosis age was 0.06 years lower for
ART than non-ART children in the restricted sample and
this difference was statistically significant. There was even
less variation in diagnosis age between ART and non-ART
children in the restricted, singleton sample, and there were
no statistically significant differences.
We observed the same pattern of results when we
assessed diagnosis age as a dichotomous outcome. Among
children in the total population sample, the odds of early
diagnosis (\4 years) were 80 % higher for ART-conceived
than non-ART-conceived children [OR 1.8 (1.6–2.1)]
(Table 3). This was reduced in the restriction sample after
adjustment for socio-demographic factors [1.4 (1.1–1.7)]
and further reduced and no longer significant in the re-
stricted, singleton sample [1.3 (0.9–1.8)]. The addition of
the two causal path factors (PTB and SGA) to the model
had no additional influence on the findings.
The findings for the three autism severity indicators we
examined are presented in Tables 4 and 5. Overall, co-
occurring ID was less common among ART-conceived
(14.7 %) than non-ART-conceived children (20.3 %)
(Table 4), and this association was statistically significant
[OR 0.7 (0.5–0.9)] (Table 5). The prevalence of co-oc-
curring ID decreased with each successive birth cohort for
both ART- and non-ART-conceived children, but a similar
differential between ART- and non-ART-conceived chil-
dren was observed for each birth cohort. In the restricted
sample there was no longer an association between ART
and co-occurring ID after adjustment for socio-demo-
graphic factors. Nor were associations observed in analyses
of the restricted, singleton sample after adjustment for
socio-demographic factors only or both socio-demographic
and causal path factors.
Although the sample for analyses of communication and
social functioning indices was limited to children born in or
before 2004 due to changes in evaluation criteria, the
findings matched those for co-occurring ID. Children
conceived with ART were significantly less likely than
those not conceived with ART to present at first evaluation
with the most severe deficits in both communication [20.9
vs. 32.4 %, OR 0.6 (0.4–0.7)] and social functioning [21.5
Table 1 continued
Total population of children with
autism
Sample restricted for socio-
demographic comparability














Payment source prenatal care
Private insurance/payment 97.1 64.4 100 100 100 100
Public source 2.9 35.6 – – – –
Payment source delivery
Private insurance/payment 97.1 64.1 100 100 100 100
Public source 2.9 35.9 – – – –
Birth plurality
Singleton 37.4 95.9 37.6 95.4 100 100
Twin 50.9 3.9 50.4 4.4 – –
Triplet/? 11.7 0.2 12.0 0.2 – –
Preterm birth
Yes 47.1 12.7 47.8 12.1 18.3 9.9
No 52.9 87.3 52.2 87.9 81.7 90.1
Small-for-gestational-age
Yes 27.8 10.5 28.8 10.2 13.1 9.1
No 72.2 89.5 71.2 89.8 86.9 90.9
The sample restricted for socio-demographic comparability excludes children whose mothers were less than 20 years of age at the time of their
birth, had less than a high school diploma, had prenatal care or delivery paid for by Medi-Cal or other public source, or had missing information
on prenatal care, inadequate prenatal care or started prenatal care in the third trimester. The sample further restricted to singletons excludes all of
the aforementioned children and additionally excludes all children born in twin or higher-order multiple birth deliveries
Data not presented if number of observations in a given category was\ 5
a Statistical testing not performed; these data are presented to provide a general sense of differences in socio-demographic characteristics and
pregnancy outcomes between study groups within and across analysis samples. These differences were accounted for in subsequent analyses
through statistical adjustment and/or sample restriction
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vs. 31.6 % OR 0.6 (0.5–0.8)]. However, neither of these
associations was evident in the restricted sample after
control of socio-demographic factors.
Discussion
The findings of this study demonstrate that two possible
reasons for the increase in autism observed generally
among ART-conceived children are that ART-conceived
children have been more likely to receive earlier diagnoses
and come to attention of the healthcare system with less
severe deficits on average than their non-ART-conceived
counterparts. This study provides important context to our
previous study of the association between ART and autism
(Fountain et al. 2015). In that earlier study, we reported
that while some of the ART-autism association in the
population overall was accounted for by socio-demo-
graphic factors, the association was nonetheless still evi-
dent even after restriction based on the same criteria
applied here and after control for many socio-demographic
confounding factors. However, the association was greatly
attenuated after accounting for causal path factors such as
multiple birth, SGA, and PTB. The residual association we
observed in that earlier study after adjustment for socio-
demographic factors might thus be explained by either a
biologic effect, i.e. an impact due to ART-conceived
children being more likely to have a sub-optimal perinatal
environment that directly impacts subsequent neurodevel-
opment, or an ascertainment effect, i.e. increased devel-
opmental monitoring of ART children who are more likely
born with one or more adverse perinatal outcomes.
Here we report that the differential in autism diagnosis
age was largely accounted for by socio-demographic dif-
ferences between ART-conceived and non-ART conceived
children, and the differentials in autism severity indicators
were entirely accounted for by socio-demographic differ-
ences. Thus, earlier identification of children with less
severe symptomatology who come from more advantaged
families appears to be one primary mechanism behind the
overall ART-autism association observed in this population
overall.
In contrast to our previous study, we found that after ad-
justment for socio-demographic factors, there was little
evidence that either diagnosis age or severity level was dif-
ferent by ART status. That is, additional restriction or
Table 2 Diagnosis age outcomes for the total sample and analytic sub-samples by birth year and ART status
Outcome and birth year Total population of children with
autism
Sample restricted for socio-demographic
comparability
Sample further restricted to
singletons
ART births Non-ART births ART births Non-ART births ART births Non-ART births
Mean age autism dx (year)
1997–1999 4.6 5.3 4.7 5.1 4.9 5.1
2000–2002 4.2 4.6 4.2 4.5 4.0 4.5
2003–2004 3.7 4.1 3.6 4.0 3.9 4.0
2005–2006 3.6 3.7 3.7 3.7 3.8 3.7
Total 1997–2006 4.0 4.5 4.0 4.4 4.1 4.4
Median age autism dx (year)
1997–1999 3.8 4.4 3.8 4.2 4.0 4.2
2000–2002 3.3 4.0 3.2 3.9 3.2 3.9
2003–2004 3.1 3.8 3.1 3.6 3.3 3.6
2005–2006 3.4 3.5 3.6 3.4 3.8 3.4
Total 1997–2006 3.3 4.0 3.3 3.9 3.6 3.9
% diagnosed at\4 years of age
1997–1999 55.4 40.4 55.5 43.9 51.3 43.9
2000–2002 63.0 48.8 63.9 52.8 69.2 52.5
2003–2004 74.4 55.9 75.2 59.1 64.9 58.7
2005–2006 68.4 65.6 67.7 67.9 66.7 67.4
Total 1997–2006 65.3 51.8 65.7 54.8 63.8 54.4
The sample restricted for socio-demographic comparability excludes children whose mothers were less than 20 years of age at the time of their
birth, had less than a high school diploma, had prenatal care or delivery paid for by Medi-Cal or other public source, or had missing information
on prenatal care, inadequate prenatal care or started prenatal care in the third trimester. The sample further restricted to singletons excludes all of
the aforementioned children and additionally excludes all children born in twin or higher-order multiple birth deliveries
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adjustment to account for the possible effects from the higher
rates of multiple birth and preterm birth among children
conceived with ART did not further impact our findings. As
mentioned, in our previous study of the overall association
between ART and autism we noted residual associations
even after adjustment for socio-demographics; these residual
associations were largely explained by perinatal factors.
While we cannot fully evaluate the mechanism underlying
those previously-described findings our current findings for
diagnosis age and case severity argue against the hypothesis
that adverse birth outcomes simply lead to further enhanced
developmental monitoring and increased case-finding in
these more vulnerable groups of children who are dispro-
portionately represented in the ART group.
We also found that the diagnosis age differential between
ART-conceived and non-ART-conceived children has
changed over time. Mean diagnosis ages declined for both
groups between 1997–1999 and 2005–2006 such that in the
latter birth cohort there was no difference in diagnosis age
between the ART and non-ART children. This finding needs
to be assessed again in later cohorts when the data become
available to determine if the finding is stable. Because we
lacked data on two severity indicators for children born in
2005–2006, we could not fully assess time trends. However,
the percentage of childrenwith co-occurring IDwas lower in
ART-conceived compared to non-ART-conceived children
in all birth cohorts including 2005–2006.
In the US overall, both trends toward earlier autism
identification and increasing identification of children with
less severe symptomatology have been documented. Re-
ports from the Autism and Developmental Disabilities
Monitoring (ADDM) Network, a population-based
surveillance system of ASD in select US sites, show the
median age of first ASD diagnosis decreased from
5.7 years for children included in the 2002 surveillance
year to 4.4 years by the 2006 surveillance year (Shattuck
et al. 2009; Autism and Developmental Monitoring Net-
work Surveillance Year 2006 Principal Investigators et al.
2009). Likewise, data from the National Survey of Chil-
dren’s Health (NSCH) indicate that while in 2003 ASD
prevalence increased gradually with child age, reaching a
peak at age 7 years, by 2007 a prevalence peak was ob-
served much earlier, by 5 years of age (Schieve et al.
2012b). ADDM data also indicate that the proportion of
children with ASD who have a co-occurring ID has de-
creased over time (Autism and Developmental Monitoring
Network Surveillance Year 2010 Principal Investigators
2014; Autism and Developmental Monitoring Network
Surveillance Year 2008 Principal Investigators 2012).
Similarly, analyses of NSCH data document that late





Restriction sample ? adjustment
for socio-demographic factorsa
Restriction, singleton
sample ? adjustment for
socio-demographic factors
Restriction, singleton
sample ? adjustment for
socio-demographic and
causal path factors









1997–1999 20.13* -0.08 -0.06 -0.10
2000–2002 -0.10* -0.04 -0.07 -0.07
2003–2004 -0.10* -0.07* -0.03 -0.001
2005–2006 -0.02 0.01 0.04 0.04
All birth years -0.10* -0.06* -0.04 -0.05
Diagnosis at\4 years of age OR (95 % CI) OR (95 % CI) OR (95 % CI) OR (95 % CI)
1997–1999 1.8 (1.3–2.7) 1.4 (0.94–2.1) 1.3 (0.7–2.4) 1.4 (0.7–2.8)
2000–2002 1.8 (1.3–2.5) 1.4 (0.95–1.9) 1.7 (0.9–3.0) 1.6 (0.9–3.1)
2003–2004 2.3 (1.5–3.5) 1.7 (1.1–2.7) 1.2 (0.6–2.3) 0.9 (0.4–1.9)
2005–2006 1.1 (0.8–1.6) 0.9 (0.6–1.3) 0.8 (0.5–1.5) 0.9 (0.5–1.6)
All birth years 1.8 (1.5–2.1) 1.4 (1.1–1.7) 1.3 (0.9–1.7) 1.3 (0.9–1.8)
The sample restricted for socio-demographic comparability excludes children whose mothers were less than 20 years of age at the time of their
birth, had less than a high school diploma, had prenatal care or delivery paid for by Medi-Cal or other public source, or had missing information
on prenatal care, inadequate prenatal care or started prenatal care in the third trimester. The sample further restricted to singletons excludes all of
the aforementioned children and additionally excludes all children born in twin or higher-order multiple birth deliveries
Statistically significant values are given in bold
* p\ 0.05
a All adjusted models included child sex, maternal age at child’s birth, maternal educational level at child’s birth, maternal race-ethnicity and
immigration status as potential confounders. The final model additionally included PTB and SGA
J Autism Dev Disord (2015) 45:2991–3003 2999
123
diagnoses of ASD in children rated by their parents as
being on the milder end of the autism spectrum were a
major contributor to the recent ASD prevalence increase
(Blumberg et al. 2013). Here we find that these two dy-
namics are also important in studying ASD prevalence
variation in population subgroups, such as ART- versus
non-ART-conceived children.
While the trend toward decreasing autism diagnosis age
that has been observed throughout the population would
seem to be the driving force behind the trends we report
here for both ART and non-ART children, the convergence
of the mean autism diagnosis age in the two study groups
that we observed in the latest time period might also be
partially attributable to changes in the population of
women accessing ART treatments. The prevalence of ART
use in California and elsewhere in the US has increased
markedly over the time period covered by this study (CDC
et al. 2012). While California’s insurance mandate that
specified group health plans offer coverage for ART pro-
cedures was in place before 1997, the increase in ART use
nonetheless demonstrates that more women were able to or
choosing to access these treatments in recent periods.
Although even in the most recent time periods, the women
who conceived via ART remained a highly select group of
the total population of women giving birth, the ART trend
might nonetheless have influenced the differential between
mothers of ART and non-ART children, such that there is
less variation between the two groups on pediatric care-
seeking behaviors.
This study should be interpreted in the context of several
limitations. Although children included in this study met
the DDS criteria for autism, they were not systematically
evaluated using a common protocol. There was likely a
modest level of under-ascertainment of both autism (chil-
dren with autism who did not seek services in DDS were
missed) and ART (ART conceptions out of state or at a
non-reporting ART clinic were missed). However, neither
of these issues is estimated to have had a major impact on
the study population (Croen et al. 2002a; CDC et al. 2012).
The children in this study were assessed for autism during
the time that the DSM-IV-TR was in place; however, some
children in the youngest birth cohorts might have been
assessed during the transition to DSM 5. Nonetheless,
given the children in our youngest birth cohort (2006) had
both mean and median autism diagnosis ages of less than
4 years, we believe the DSM 5, which was published in
Table 4 Autism severity indicators for the total sample and analytic sub-samples by birth year and ART status
Outcome and birth year Total population of children with
autism
Sample restricted for socio-demographic
comparability
Sample further restricted to
singletons
ART births Non-ART births ART births Non-ART births ART births Non-ART births
% diagnosed with co-occurring ID
1997–1999 22.3 27.0 23.8 24.3 15.4 23.9
2000–2002 17.6 22.2 18.1 18.9 15.4 19.0
2003–2004 11.1 17.4 9.2 13.5 2.7 13.4
2005–2006 8.1 12.7 7.9 10.1 10.5 10.5
Total 1997–2006 14.7 20.3 14.6 17.5 11.4 17.4
% low score (first tertile) communication index at first DDS evaluation
1997–1999 23.2 32.2 23.5 26.8 – –
2000–2002 21.3 33.3 21.6 27.6 – –
2003–2004 17.8 31.0 14.5 25.2 – –
2005–2006 – – – – – –
Total 1997–2004 20.9 32.4 20.3 26.8
% low score (first tertile) social functioning index at first DDS evaluation
1997–1999 16.7 32.9 16.3 29.5 – –
2000–2002 22.7 31.7 23.9 28.6 – –
2003–2004 25.6 29.2 24.1 25.9 – –
2005–2006 – – – – – –
Total 1997–2004 21.5 31.6 21.6 28.3
The sample restricted for socio-demographic comparability excludes children whose mothers were less than 20 years of age at the time of their
birth, had less than a high school diploma, had prenatal care or delivery paid for by Medi-Cal or other public source, or had missing information
on prenatal care, inadequate prenatal care or started prenatal care in the third trimester. The sample further restricted to singletons excludes all of
the aforementioned children and additionally excludes all children born in twin or higher-order multiple birth deliveries
Data not presented if number of observations in a given category was\5
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2013 when these children were 7 years of age, had minimal
impact on autism identification. Our assessment of social
and communication severity indicators was hampered by
changes in the criteria used during the time period for this
study. While we had consistent reporting of co-occurring
ID during the entire time frame, IQ scores are not uni-
formly reported in the DDS for children served under the
autism eligibility criterion. Moreover, previous reliability
studies (Croen et al. 2002b) and the low overall prevalence
of co-occurring ID reported here in comparison to other US
surveillance reports (Autism and Developmental Monitor-
ing Network Surveillance Year 2010 Principal Investiga-
tors 2014; Autism and Developmental Monitoring Network
Surveillance Year 2008 Principal Investigators 2012) are
suggestive of under-reporting. While we lacked data to
determine if such under-reporting is differential by ART
status, it is encouraging that our results point to convergent
validity for our various severity indicators; the findings
from the communication and social functioning severity
indicators matched well with each other and with the
findings for co-occurring ID. We were also not able to
assess communication and social functioning indicators in
the restricted, singleton sample because of sample size
constraints. However, given the effects observed in the
total sample were already notably attenuated after control
for socio-demographics, additional restriction on and con-
trol for perinatal risk factors were unlikely to have addi-
tional impacts. We were only able to assess the most
intensive fertility treatments, those classified as ART, in
this analysis. However, conception with non-ART ovarian
stimulation treatments has been estimated to be four times
as common as ART (Schieve et al. 2009), and children
conceived with these treatments face similar increases in
adverse perinatal outcomes as ART-conceived children
(Schieve et al. 2009; Ombelet et al. 2006) and might also
face increased risk for autism (Hvidtjorn et al. 2011). We














sample ? adjustment for
socio-demographic and
causal path factors
Co-occurring ID OR (95 % CI) OR (95 % CI) OR (95 % CI) OR (95 % CI)
1997–1999 0.8 (0.5–1.2) 1.1 (0.7–1.9) 0.8 (0.3–1.8) 0.8 (0.3–2.0)
2000–2002 0.8 (0.5–1.1) 1.1 (0.7–1.7) 0.8 (0.4–2.0) 1.0 (0.5–2.2)
2003–2004 0.6 (0.3–1.1) 0.8 (0.4–1.5) – –
2005–2006 0.6 (0.3–1.1) 1.1 (0.5–2.1) 1.6 (0.7–3.7) 1.3 (0.5–3.4)
All birth years 0.7 (0.5–0.9) 1.0 (0.8–1.3) 0.8 (0.5–1.2) 0.8 (0.5–1.3)
Low score (first tertile) communication
index at first DDS evaluation
OR (95 % CI) OR (95 % CI)
1997–1999 0.6 (0.4–1.0) 1.1 (0.7–1.8)
2000–2002 0.5 (0.4–0.8) 0.9 (0.6–1.4)
2003–2004 0.5 (0.3–0.8) 0.6 (0.3–1.1)
2005–2006 – –
All birth years 0.6 (0.4–0.7) 0.9 (0.7–1.2)
Low score (first tertile) social functioning
index at first DDS evaluation
OR (95 % CI) OR (95 % CI)
1997–1999 0.4 (0.3–0.7) 0.5 (0.3–0.9)
2000–2002 0.6 (0.4–0.9) 0.9 (0.6–1.4)
2003–2004 0.8 (0.5–1.3) 1.1 (0.6–1.9)
2005–2006 – –
All birth years 0.6 (0.5–0.8) 0.8 (0.6–1.1)
The sample restricted for socio-demographic comparability excludes children whose mothers were less than 20 years of age at the time of their
birth, had less than a high school diploma, had prenatal care or delivery paid for by Medi-Cal or other public source, or had missing information
on prenatal care, inadequate prenatal care or started prenatal care in the third trimester. The sample further restricted to singletons excludes all of
the aforementioned children and additionally excludes all children born in twin or higher-order multiple birth deliveries
Statistically significant values are given in bold
a All adjusted models included child sex, maternal age at child’s birth, maternal educational level at child’s birth, maternal race-ethnicity and
immigration status as potential confounders. The final model additionally included PTB and SGA
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also lacked data to fully evaluate autism symptomatology
in terms of co-occurring disorders such as mood and
anxiety disorders. Finally, we were not able to account for
the possibility that the children included in our study
samples were not completely independent. Given the wide
time frame included in this study, it is possible some sib-
ling sets were included; this includes some sets from
multiple-birth deliveries in our first two analytic samples.
This study also has a number of strengths. This is one
of the largest available samples of children with data on
both ART use and autism. The study is population-based
and the linkage rates for the various population-based
datasets were high. Data were available for a number of
important socio-demographic confounding factors as well
as for perinatal outcomes found previously to be associ-
ated with both ART and autism in US populations
(Schieve et al. 2007; Croen et al. 2002b; Durkin et al.
2008; Durkin et al. 2010; Bilder et al. 2009; Mandell
et al. 2009; Schieve et al. 2012a). Thus, we were able to
thoroughly explore the underlying reasons for the initial
differences observed between ART-and non-ART-con-
ceived children.
Children conceived with ART are identified as having
autism earlier and are more likely to present with less
severe symptomatology than children from the general
population. However, after adjustment for the differences
in the socio-demographic profiles of the two groups, the
diagnosis age differentials were greatly attenuated and
there were no differences in autism symptomatology indi-
cating that ascertainment issues related to SES, not ART
per se, are likely the driving influence. These findings shed
light on one aspect of the emerging data from several
studies that report that overall, children conceived with
ART are more likely to subsequently be identified as
having autism. These findings also have broader implica-
tions for understanding ASD prevalence, as they document
that ascertainment is quite variable across population sub-
groups and these differentials may have changed over time.
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